News Sentiment

IMNN sentiment intelligence

Imunon Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 48 Balanced news tone 56 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.02 Week of 10 Jul 2026
Weighted tone 48/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 48

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

+5.8% over one week, +0.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

OTC Markets Life Sciences Investor Forum: Stacy Lindborg, PhD, President, CEO, and Board Director, of Imunon with Zacks SCR’s David Bautz, PhD

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction 5.8% Price confirming higher
Trend fit Trend inactive 0.0% over four weeks
Fair value -80.2% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 46
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 48
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 16
TradingView 12
Market source 5
GlobeNewswire 5
Investing.com Nigeria 3
GuruFocus 2
simplywall.st 2
Zacks Small Cap Research 1

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 15
Balance sheet 7
Analyst action 2
Deals and strategy 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-56 of 56
TradingView Direct company coverage

Imunon, Inc. Actuals & Estimates (NASDAQ:IMNN)

This article provides an overview of Imunon, Inc. (NASDAQ:IMNN) stock, including its current price, historical performance, and analyst forecasts. It also details the company's financial actuals and estimates, such as earnings, revenue, net income, and upcoming earnings release d

Tone
Negative 35/100
Event
Earnings
Published
25 Jun 2026 23:38
Source
TradingView
TradingView Direct company coverage

IMNN Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for Imunon, Inc. (IMNN) stock, based on analyst opinions. It details the company's current stock performance, historical highs and lows, market capitalization, earnings reports, and technical analysis indicators. The article also

Tone
Negative 38/100
Event
Analyst action
Published
25 Jun 2026 19:10
Source
TradingView